Commentary: On the use of pitressin in infants with neurogenic diabetes insipidue.
D000328:Adult; D001834:Body Water / Q000378:metabolism; D001927:Brain Diseases / Q000150:complications*; D002675:Child, Preschool; D003919:Diabetes Insipidus / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006801:Humans; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D014667:Vasopressins / Q000009:adverse effects / Q000627:therapeutic use*
D014667:Vasopressins